Area of research
Immunology · Molecular Biology
Research interest
Research interests include Nanocarriers, Chemistry, Nanocapsules, Antibody, In vivo, and Cancer research.
Biodegradable Carbonate Nanogels Loaded with Anti MFAP‐5 siRNA for Anti‐stromal Therapy of Hepatocellular Carcinoma
Unfolding and Degradation of Micellar Immunodrug Carriers Derived From End Group Modified Aliphatic Poly(Carbonate)s with Acid‐Responsive Ketal Side Groups
Nanobodies Outperform Antibodies – Rapid Functionalization with Equal In Vivo Targeting Properties
Co-delivery of STING and TLR7/8 agonists in antigen-based nanocapsules to dendritic cells enhances CD8+ T cell-mediated melanoma remission
The mRNA-Binding Protein KSRP Limits the Inflammatory Response of Macrophages
A hepatocellular carcinoma model with and without parenchymal liver damage that integrates technical and pathophysiological advantages for therapy testing
Uptake of extracellular vesicles into immune cells is enhanced by the protein corona
The Role of LFA-1 for the Differentiation and Function of Regulatory T Cells—Lessons Learned from Different Transgenic Mouse Models
Delivery of Immunostimulatory Cargos in Nanocarriers Enhances Anti-Tumoral Nanovaccine Efficacy
Achieving dendritic cell subset-specific targeting in vivo by site-directed conjugation of targeting antibodies to nanocarriers
Multicomponent encapsulation into fully degradable protein nanocarriers <i>via</i> interfacial azide–alkyne click reaction in miniemulsion allows the co-delivery of immunotherapeutics
PEG Spacer Length Substantially Affects Antibody-Based Nanocarrier Targeting of Dendritic Cell Subsets
Density of Conjugated Antibody Determines the Extent of Fc Receptor Dependent Capture of Nanoparticles by Liver Sinusoidal Endothelial Cells
Unraveling the In Vivo Protein Corona
Encapsulation of polyprodrugs enables an efficient and controlled release of dexamethasone
Enhanced CAR–T cell activity against solid tumors by vaccine boosting through the chimeric receptor
Controlling protein interactions in blood for effective liver immunosuppressive therapy by silica nanocapsules
Polymeric hepatitis C virus non-structural protein 5A nanocapsules induce intrahepatic antigen-specific immune responses
Biodegradable Protein Nanocontainers
Monophosphoryl lipid A coating of hydroxyethyl starch nanocapsules drastically increases uptake and maturation by dendritic cells while minimizing the adjuvant dosage
Nanocapsules generated out of a polymeric dexamethasone shell suppress the inflammatory response of liver macrophages